Nanjing Delova Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NANJING DELOVA
NANJING DELOVA has one approved drug.
There is one US patent protecting NANJING DELOVA drugs.
Summary for Nanjing Delova
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Nanjing Delova
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nanjing Delova | QAMZOVA | meloxicam | SOLUTION;INTRAVENOUS | 217593-001 | Apr 22, 2025 | RX | Yes | Yes | 12,059,423 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Nanjing Delova Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 7374501 | ⤷ Start Trial |
| South Korea | 20210007951 | ⤷ Start Trial |
| China | 116327959 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
